Invesco Portfolio holdings
Invesco Ltd., founded in 1978 and headquartered in Atlanta, Georgia, is a global investment management firm managing hundreds of billions in assets across a diverse range of products, including mutual funds, exchange-traded funds (ETFs), and institutional portfolios. Known for its blend of active and passive investment strategies, Invesco serves individual investors, financial advisors, and institutions, with a strong presence in North America, Europe, and Asia, bolstered by acquisitions like OppenheimerFunds in 2019. The firm offers specialized solutions in equities, fixed income, real estate, and alternatives, leveraging its global research capabilities to cater to varying market needs. Invesco’s commitment to innovation and client-focused investing has solidified its reputation as a versatile player in the asset management industry.
Top Buys
| 1 |
Walmart
WMT
|
$1.12B |
| 2 |
Microsoft
MSFT
|
$700M |
| 3 |
Walt Disney
DIS
|
$589M |
| 4 |
Linde
LIN
|
$549M |
| 5 |
Apple
AAPL
|
$486M |
Top Sells
| 1 |
Yum China
YUMC
|
$518M |
| 2 |
Invesco S&P 500 Low Volatility ETF
SPLV
|
$480M |
| 3 |
Synopsys
SNPS
|
$424M |
| 4 |
Workday
WDAY
|
$406M |
| 5 |
Meta Platforms (Facebook)
META
|
$364M |
Sector Composition
| 1 | Technology | 23.57% |
| 2 | Financials | 12.22% |
| 3 | Industrials | 11.88% |
| 4 | Healthcare | 11.02% |
| 5 | Consumer Discretionary | 10.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
101
Amgen
AMGN
$155B
| $880M | 0.19% | 3,096,507 -388,335 | -11% | -$110M |
|
102
Vertex Pharmaceuticals
VRTX
$100B
| $874M | 0.19% | 2,091,143 -150,964 | -7% | -$63.1M |
|
103
MPLX
MPLX
$51.8B
| $865M | 0.19% | 20,816,982 -27,960 | -0.1% | -$1.16M |
|
104
Boston Scientific
BSX
$156B
| $863M | 0.19% | 12,601,198 +53,419 | +0.4% | +$3.66M |
|
105
Zimmer Biomet
ZBH
$21B
| $855M | 0.18% | 6,476,428 +270,910 | +4% | +$35.8M |
|
106
DuPont de Nemours
DD
$32.2B
| $850M | 0.18% | 11,087,564 +1,516,422 | +16% | +$116M |
|
107
Roper Technologies
ROP
$56.6B
| $846M | 0.18% | 1,508,985 +133,203 | +10% | +$74.7M |
|
108
Citigroup
C
$178B
| $839M | 0.18% | 13,271,545 -923,872 | -7% | -$58.4M |
|
109
CME Group
CME
$96B
| $834M | 0.18% | 3,873,911 +768,139 | +25% | +$165M |
|
110
Western Midstream Partners
WES
$15B
| $831M | 0.18% | 23,374,407 +27,347 | +0.1% | +$972K |
|
111
Gilead Sciences
GILD
$140B
| $826M | 0.18% | 11,279,965 -368,836 | -3% | -$27M |
|
112
CRH
CRH
$75.9B
| $825M | 0.18% | 9,560,579 -530,397 | -5% | -$45.8M |
|
113
TJX Companies
TJX
$152B
| $818M | 0.18% | 8,060,712 -166,214 | -2% | -$16.9M |
|
114
Pfizer
PFE
$141B
| $814M | 0.17% | 29,325,335 +5,199,072 | +22% | +$144M |
|
115
Monolithic Power Systems
MPWR
$40B
| $813M | 0.17% | 1,200,499 -62,076 | -5% | -$42.1M |
|
116
Suncor Energy
SU
$50.1B
| $809M | 0.17% | 21,908,752 +701,449 | +3% | +$25.9M |
|
117
TransDigm Group
TDG
$78.8B
| $807M | 0.17% | 655,568 -36,646 | -5% | -$45.1M |
|
118
Constellation Brands
STZ
$28.5B
| $806M | 0.17% | 2,964,020 -176,743 | -6% | -$48M |
|
119
Oracle
ORCL
$635B
| $801M | 0.17% | 6,380,655 +204,819 | +3% | +$25.7M |
|
120
Citizens Financial Group
CFG
$22.6B
| $798M | 0.17% | 21,976,867 +4,670,576 | +27% | +$169M |
|
121
Idexx Laboratories
IDXX
$51.8B
| $794M | 0.17% | 1,470,111 +143,518 | +11% | +$77.5M |
|
122
RTX Corp
RTX
$212B
| $777M | 0.17% | 7,967,672 +26,487 | +0.3% | +$2.58M |
|
123
Thermo Fisher Scientific
TMO
$186B
| $774M | 0.17% | 1,332,200 -341,743 | -20% | -$199M |
|
124
DexCom
DXCM
$29.5B
| $773M | 0.17% | 5,574,181 +2,030,865 | +57% | +$282M |
|
125
IBM
IBM
$227B
| $768M | 0.17% | 4,021,653 -499,685 | -11% | -$95.4M |
|